US Patent 8409570 Method of inducing apoptosis using anti-DR5 antibodies
Patent 8409570 was granted and assigned to Genentech on April, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+239 characters)
Article
Patent abstract
The invention concerns anti-DR5 antibodies with improved properties, compositions comprising such antibodies, methods and means for making such antibodies, and their therapeutic use, in particular in the treatment of cancer.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Avi J. Ashkenazi0
Camellia W. Adams0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08409570 Method of inducing apoptosis using anti-DR5 antibodies US Patent 8409570 Method of inducing apoptosis using anti-DR5 antibodies
Infobox
Patent Number
084095700
Patent Number
84095700
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084095700
Date of Patent
April 2, 2013
0Patent Application Number
132273910
Date Filed
September 7, 2011
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08409570 Method of inducing apoptosis using anti-DR5 antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08409570
Date of patent
April 2, 2013
Patent application number
13227391
Date Filed
September 7, 2011
Patent primary examiner
Find more entities like US Patent 8409570 Method of inducing apoptosis using anti-DR5 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
